安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Biologicals - World Health Organization (WHO)
The beneficial impact of biologicals is as diverse as the types of products themselves: Vaccines are one of the most powerful and cost-effective ways to reduce the global burden of disease and are estimated to save 2–3 million lives every year
- Call for applications closed - 2025 Introductory course for biologics . . .
Proposed dates for the 2025 Introductory Course for Biologics Development and Manufacturing are: Monday, June 16, 2025 – Friday, June 27, 2025 (2 Weeks) Course Objectives After completing the course, participants will have basic and primary knowledge about various areas that are related to biologics manufacturing
- Biologicals - World Health Organization (WHO)
Biologicals are a class of medicines made from living cells taken from plants, animals or bacteria These cells are use in creating many types of health care products, including vaccines This group of medicines also includes products derived from human blood and plasma for the treatment of many life-threatening diseases and for surgical procedures
- Guidelines for Biologicals - World Health Organization (WHO)
Recommendations to assure the quality, safety and efficacy of BCG vaccines, Annex 3, TRS No 979
- WHO good manufacturing practices for biological products
93 Annex 2 WHO good manufacturing practices for biological products Replacement of Annex 1 of WHO Technical Report Series, No 822
- Introductory Course for Biologics Development and Manufacturing . . .
Low- and Middle-Income Countries (LMICs) face significant inequity in terms of access to vaccines and other biologics and are making efforts to establish biological manufacturing in their regions Establishing such manufacturing capacity, through bilateral technology transfer or through local R D efforts is often hindered by the lack of a trained workforce in biomanufacturing To address this
- Health products policy and standards - World Health Organization (WHO)
INNs have been assigned to biological products since the early days of the INN Programme As well as many names for individual substances, animal insulin preparations were given an INN in Recommended list 3 in 1959
- WHO adds LC16m8 mpox vaccine to Emergency Use Listing
LC16m8 is a vaccine developed and manufactured by KM Biologics in Japan The Technical Advisory Group (TAG) for EUL of vaccines convened to discuss the outcome of the LC16m8 vaccine review, including the product and programmatic suitability assessments
|
|
|